Why Freshly Harvested Cells Differ From Bottles Biologic Products
By Mark L. Barba, MD
Orthopedic Surgeon | Hip and Knee Reconstruction | Joint Preservation | Orthobiologics
Patients with hip and knee pain often want clear answers about what is causing their symptoms and what treatment options may help. In this message, I share practical, evidence-based information on arthritis, joint preservation, replacement surgery, and selected orthobiologic treatments to help patients make informed decisions about their care.
Why Freshly Harvested Cells Differ From Bottled Biologic Products
As interest in orthobiologic treatments grows, patients often encounter many different terms, including stem cells, amniotic tissue products, bone marrow concentrate, and regenerative injections. One question that frequently arises is why some treatments involve cells harvested from the patient at the time of the procedure, while others are commercially packaged biologic products.
Understanding the differences between these approaches can help clarify why outcomes and expectations may vary.
What Are Freshly Harvested Orthobiologic Cells?
Some orthobiologic treatments use cells obtained directly from the patient during the procedure. Two common sources are:
- Bone marrow aspirate concentrate (BMAC)
- Adipose (fat) tissue–derived biologic preparations
These tissues contain a mixture of biologically active components, including:
- progenitor cells
- platelets
- growth factors
- signaling molecules involved in healing
Because these materials are processed and used during the same procedure, the cellular components are fresh and metabolically active.
What Are Bottled or Commercial Biologic Products?
Some clinics advertise injectable products derived from amniotic tissue, umbilical cord tissue, or other birth tissues. These products are typically:
- processed by tissue banks
- frozen or dehydrated
- stored and shipped for later use
While these products may contain structural proteins or signaling molecules, most commercially available versions contain few or no living cells by the time they are injected.
The processing, freezing, and storage required to prepare these materials can affect cellular viability.
Why Cellular Viability Matters
Cells that are alive and metabolically active are capable of responding to their environment and releasing biologic signals. These signals may help regulate inflammation and influence tissue repair.
When cells are no longer viable, the product may still contain biologic scaffolds or growth factors, but it does not function in the same way as living cellular material.
This difference is one reason physicians who work extensively with orthobiologic treatments often emphasize freshly harvested biologic preparations.
Regulatory Considerations
Another factor to consider is how different biologic products are regulated.
Treatments that use a patient’s own tissue during the same procedure are generally regulated differently from commercially manufactured biologic products. These regulatory frameworks are designed to ensure safety while recognizing the differences between autologous tissues and manufactured products.
Patients should always feel comfortable asking questions about what is being injected and how it is prepared.
Where These Treatments Fit in Orthopedic Care
Orthobiologic treatments are an evolving area of orthopedic medicine. Approaches using bone marrow concentrate, PRP, and other biologic preparations are being studied as potential tools for:
- early arthritis
- tendon injuries
- ligament injuries
- joint preservation strategies
It is important to understand that these treatments are not cures for arthritis, and not every patient is an ideal candidate.
A careful evaluation remains essential when deciding whether biologic treatment may be appropriate.
Closing Thoughts
Orthobiologic therapies continue to evolve as research improves our understanding of how biologic signals influence healing and inflammation.
Freshly harvested biologic preparations differ from many commercially packaged products primarily because they may contain living, active cellular components obtained directly from the patient at the time of treatment.
As with all medical treatments, careful evaluation and individualized care remain the most important factors in determining the best approach.
If you are dealing with persistent hip or knee pain and want to understand your treatment options, an evaluation with an orthopedic specialist can help determine the most appropriate next step.
